Investigating the trafficking mechanisms and signaling consequences of dopamine receptor primary cilia localization
Investigating the trafficking mechanisms and signaling consequences of dopamine receptor primary cilia localization
批准号:
10464628
负责人:
Rita Reale Fagan
金额:
$6.72万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2025-04-30
关键词:
AddressBindingBinding ProteinsBiochemicalBiological AssayBiosensorBrainCRISPR/Cas technologyCell Culture TechniquesCell LineCell membraneCell modelCell surfaceCellsCiliaClustered Regularly Interspaced Short Palindromic RepeatsCo-ImmunoprecipitationsCognitionComplexCorpus striatum structureCultured CellsCyclic AMPDefectDevelopmentDopamineDopamine ReceptorG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGenesGenetic DiseasesGoalsLearningLightMediatingMediator of activation proteinModelingMolecularMorphologyMovementMusNeurologic SymptomsNeuromodulatorNeuronsNeurotransmittersPathway interactionsPhysiologicalPopulationProteinsProteomicsPublishingRattusReceptor ActivationReceptor SignalingRegulationReportingRewardsScientistSensorySignal PathwaySignal TransductionSliceStructural ProteinSurfaceTechniquesTestingTimeTrainingValidationWorkcareerciliopathyexperimental studymonoamineneuroregulationnovelprotein transportreceptortooltrafficking
中文摘要
项目总结/摘要
纤毛病是由纤毛损失或功能失调的信号传导引起的遗传性疾病,其特征在于多种
包括神经系统症状G蛋白偶联受体(GPCR)的一个子集富含
初级纤毛,包括调节性神经递质多巴胺的受体。多巴胺受体(DR)纤毛
十年前就有人描述了局部化,但基本的细胞贩运机制仍然主要是
未定义。有趣的是,我们实验室和其他人发表的工作支持DR纤毛
靶向机制是选择性的并且不同于其他睫状GPCR。此外,纤毛特异性DR的影响
对神经元功能和活性的信号传导在很大程度上未被探索。
该提议旨在测试两个中心假设:(1)DR纤毛运输在机制上不同于
GPCR纤毛定位的普遍理解,和(2)来自初级纤毛的DR信号影响
多巴胺能刺激下游的神经元cAMP。我们将采取多方面的办法,
这些问题使用IMCD 3细胞,一个建立的纤毛细胞培养模型,理想的研究分子
支持GPCR纤毛运输的机制。首先,我们将阐明和完善DR序列基序
这是纤毛定位的必要条件和充分条件。然后,我们将采用无偏见的定量蛋白质组学来揭示
新的因子,直接结合DR,纤毛定位所需的。接下来,我们将测试DR纤毛是否
靶向需要纤毛运输机制的不同子集,从其他纤毛定位的GPCR使用标准
生物化学和CRISPR/Cas9基因编辑技术。此外,本提案将检验以下假设:
在异源细胞中DR纤毛运输所需的结构决定簇和纤毛运输蛋白是
在纹状体中等多刺神经元中保守,内源性DR背景。最后,我们将研究
在纹状体神经元中,纤毛特异性DR激活的下游后果,集中于cAMP。拟议
实验将大大扩展我们对选择性纤毛运输机制的理解,并成为第一个
检查神经元中来自初级纤毛的局部DR信号的影响。此外,培训计划和
本建议书中详述的机构支持为推动申请人实现
作为一名独立的科学家。
英文摘要
Project Summary/Abstract
Ciliopathies are genetic disorders that arise from cilia loss or dysfunctional signaling, characterized by a multitude
of defects, including neurological symptoms. A subset of G protein-coupled receptors (GPCRs) are enriched in
primary cilia, including receptors for the modulatory neurotransmitter, dopamine. Dopamine receptor (DR) cilia
localization was described a decade ago, yet the underlying cellular trafficking machinery remains largely
undefined. Interestingly, published work from our lab and others supports the hypothesis that the DR cilia
targeting mechanism is selective and distinct from other ciliary GPCRs. Moreover, the impact of cilia-specific DR
signaling on neuronal function and activity is largely unexplored.
This proposal aims to test two central hypotheses: (1) DR cilia trafficking is mechanistically distinct from the
prevailing understanding of GPCR cilia localization, and (2) DR signaling from the primary cilium impacts
neuronal cAMP downstream of dopaminergic stimulation. We will take a multifaceted approach in order to tackle
these questions using IMCD3 cells, an established ciliated cell culture model ideal for investigating the molecular
mechanisms underpinning GPCR cilia trafficking. First, we will elucidate and refine the DR sequence motifs
necessary and sufficient for cilia localization. We will then employ unbiased, quantitative proteomics to uncover
novel factors that bind directly to DRs, and are required for cilia localization. Next, we will test whether DR cilia
targeting requires a distinct subset of cilia transport machinery from other cilia-localized GPCRs using standard
biochemical and CRISPR/Cas9 gene editing techniques. Furthermore, this proposal will test the hypothesis that
the structural determinants and cilia trafficking proteins required for DR cilia trafficking in heterologous cells are
conserved in striatal medium spiny neurons, the endogenous DR context. Finally, we will examine the
downstream consequences of cilia-specific DR activation, focusing on cAMP, in striatal neurons. The proposed
experiments will greatly expand our understanding of selective ciliary trafficking mechanisms, and be the first to
examine the impact of localized DR signaling from primary cilia in neurons. In addition, the training plan and
institutional support detailed in this proposal provide exceptional tools for advancing the applicant towards a
career as an independent scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the trafficking mechanisms and signaling consequences of dopamine receptor primary cilia localization
-
批准号:10595554
-
项目类别:
-
资助金额:$6.95万
-
财政年份:2022
-
负责人:Rita Reale Fagan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: